Cutler Group LP Sesen Bio, Inc. Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.49 - $0.61 $1,573 - $1,959	-3,212 Reduced 96.98%	100 $0
Q3 2022 Oct 25, 2022	BUY	$0.0 - $0.93 $0 - $2,325	2,500 Added 307.88%	3,312 $1,000
Q2 2022 Aug 04, 2022	BUY	$0.38 - $0.89 $270 - $633	712 Added 712.0%	812 $0
Q1 2022 Apr 14, 2022	SELL	$0.58 - $0.86 $9,403 - $13,943	-16,213 Reduced 99.39%	100 $0
Q4 2021 Jan 18, 2022	SELL	$0.73 - $1.28 $23,414 - $41,056	-32,075 Reduced 66.29%	16,313 $13,000
Q3 2021 Oct 26, 2021	BUY	$0.77 - $4.91 $2,048 - $13,060	2,660 Added 5.82%	48,388 $38,000
Q2 2021 Jul 19, 2021	BUY	$2.18 - $4.66 $44,624 - $95,390	20,470 Added 81.04%	45,728 $211,000
Q1 2021 Apr 26, 2021	BUY	$1.3 - $3.24 $16,650 - $41,497	12,808 Added 102.88%	25,258 $65,000
Q4 2020 Jan 21, 2021	BUY	$1.01 - $1.77 $12,574 - $22,036	12,450 New	12,450 $16,000
Q4 2019 Feb 06, 2020	SELL	$0.89 - $1.5 $979 - $1,650	-1,100 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$0.95 - $2.46 $1,045 - $2,706	1,100 New	1,100 $1,000
Q1 2019 May 10, 2019	SELL	$0.69 - $1.47 $1,698 - $3,617	-2,461 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$0.96 - $2.04 $1,728 - $3,672	1,800 Added 272.31%	2,461 $3,000
Q3 2018 Nov 07, 2018	BUY	$1.54 - $2.38 $308 - $476	200 Added 43.38%	661 $1,000
Q2 2018 Aug 10, 2018	BUY	$1.04 - $3.29 $479 - $1,516	461 New	461 $0

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.